Literature DB >> 26863478

Multifocal FIGO Stage IA1 Squamous Carcinoma of the Cervix: Criteria for Identification, Staging, and its Good Clinical Outcome.

Elizabeth Day1, Siobhan Duffy, Gareth Bryson, Sheeba Syed, Smruta Shanbhag, Kevin Burton, Rhona Lindsay, Nadeem Siddiqui, David Millan.   

Abstract

Multifocal squamous cervical carcinomas account for up to 25% of IA1 tumors identified on excisional biopsy, yet there are no uniformly accepted histopathologic criteria for defining and staging these lesions. Here, we use a strict case definition and meticulous specimen processing from colposcopist to pathologist to identify and follow-up 25 cases of multifocal IA1 cervical squamous carcinomas identified in excisional biopsies. We stage these tumors using the dimensions of the largest focus and a minimum of 2 mm between each foci to define multifocality. The cases are followed up for a median of 7 yr with no episodes of tumor recurrence or metastasis. We also show that the prevalence of residual preinvasive (20%) and invasive disease (5%) on repeat excision/surgery are comparable to data available for unifocal IA1 cases. Our study supports the hypothesis that multifocal lesions should be staged according to largest individual focus of invasion and we emphasize the importance of meticulous specimen handling to appropriately identify multifocal tumors. In addition, our analysis suggests that outcomes are comparable to unifocal lesions and supports the hypothesis that they may be managed in a similar manner.

Entities:  

Mesh:

Year:  2016        PMID: 26863478     DOI: 10.1097/PGP.0000000000000269

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

Review 1.  The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Authors:  Maria Rosaria Raspollini; Sigurd F Lax; W Glenn McCluggage
Journal:  Virchows Arch       Date:  2018-05-24       Impact factor: 4.064

Review 2.  [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]

Authors:  Lars-Christian Horn; Matthias W Beckmann; Markus Follmann; Martin C Koch; Monika Nothacker; Birgit Pöschel; Frederik Stübs; Dietmar Schmidt; Anne Kathrin Höhn
Journal:  Pathologie (Heidelb)       Date:  2022-02-21

Review 3.  Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.

Authors:  Kay J Park; Andres Roma; Naveena Singh; C Blake Gilks; Esther Oliva; Nadeem Abu-Rustum; Pedro T Ramirez; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

4.  Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists.

Authors:  W Glenn McCluggage; Joseph T Rabban; Naveena Singh; Esther Oliva
Journal:  Int J Gynecol Pathol       Date:  2021-03       Impact factor: 3.326

Review 5.  Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Authors:  Giovanni Barillari; Roberto Bei; Vittorio Manzari; Andrea Modesti
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.